Filter By Industry
Filter By Tag

Newsroom

Mobius Therapeutics Press releases

1 - 3 of 3 Press Releases

Mobius Therapeutics™ Receives Payment Indicator for Reimbursement of Mitosol®
Mar 11, 2013
(ST. LOUIS) — Mobius Therapeutics™, LLC, a St. Louis-based ophthalmic company, has received notice from the Center for Medicare Services (CMS) of an Outpatient Prospective Payment System (OPPS) Payment Indicator “K2” for the code J7315...

Mobius Therapeutics™ Announces Assignment of HCPCS Code for Mitosol®
Nov 08, 2012
Centers for Medicare and Medicaid Services Assigns Code for Billing Medicare, Private Insurance

Mobius Therapeutics™ Receives Final FDA Approval for New Glaucoma Drug
Feb 09, 2012
FDA Approves Mitosol® for Immediate Production and Use in Glaucoma Surgery


Mobius Therapeutics RSS Feed